About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Chimeric Gene the Driving Factor for Hepatocellular Carcinoma

by Anjali Aryamvally on November 25, 2017 at 3:21 PM
Font : A-A+

Chimeric Gene the Driving Factor for Hepatocellular Carcinoma

New study has identified the genetic key that dives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar hepatocellular carcinoma (FL-HCC), which mainly strikes adolescents and young adults.

Sanford Simon, who conducted the research as head of The Rockefeller University's Laboratory of Cellular Biophysics, describes the culprit as a "chimeric gene," a mutation created when two genes fuse together. These genes normally sit far apart from each other, separated by some 400,000 base pairs, the building blocks of DNA that combine to form genes.

Advertisement


The chimeric gene, which Simon's lab first characterized three years ago, has been found in each of the hundreds of FL-HCC patients tested for the mutation.

A disease mechanism revealed

Having confirmed the chimeric gene as a hallmark of the disease, Simon set out to explore if and how it may cause these malignant tumors. He worked with Scott Lowe, a cancer geneticist at the Memorial Sloan Kettering Cancer Center, to develop a mouse model of FL-HCC.
Advertisement

In work published in the Proceedings of the National Academy of Sciences, the scientists used CRISPR gene editing, a highly precise tool for manipulating DNA, to generate mice that carry the 400,000 base-pair deletion and produce the chimeric gene. Edward Kastenhuber, a graduate student in Lowe's lab, found that these mice develop liver tumors that mimic the biology of the tumors found in humans with FL-HCC, suggesting that the deletion is in itself sufficient to cause the cancer--other alterations are not necessary for tumors to grow.

However, this experiment left open the question of precisely how the deletion spurs cancer: by eliminating genes that normally would suppress the growth of tumors, or by introducing the chimeric gene. Another experiment, in which mice with the fused gene but no deletion in the genome developed tumors, proved that it's the mutation, not the missing DNA as such, that causes the disease.

With the chimeric gene firmly established as the driver of the disease, and its cellular mechanisms defined, Simon and his team--including Gadi Lalazar, of Rockefeller's Clinical Scholars Program, and graduate student David Requena--are now working to identify potential targets for drugs to treat the disease.

New concepts for therapy

Among these drug targets is a protein produced from the fused gene that belongs to a family of enzymes called kinases. These enzymes are often mutated in cancers. "In fact," Simon explains, "some of the most successful cancer therapies available, including Gleevec, act by targeting specific kinases."

The researchers showed that disruption of the fused gene's kinase activity impaired the formation of tumors in mice--a finding that has strengthened their confidence that agents aimed at targeting this activity or its consequences might be effective against FL-HCC.

The team is also studying the effects of targeting a number of cellular signaling systems that have previously been implicated in other cancers, and that speed tumor growth when they become overactive in FL-HCC patients. And they will be using their new mouse model as a system to test the effectiveness of new therapies prior to initiating clinical trials in patients.

Simon first became interested in FL-HCC nine years ago, when his 12-year-old daughter Elana was diagnosed with the disease. (Now 21, Elana is a senior at Harvard, and a lead author on earlier reports characterizing the genomics of the disease.) He continues to embrace the challenge the cancer presents and attributes the latest breakthroughs to an "incredible perfect storm" of advances in all of the sciences, thanks to decades of public investment in basic research.

"Here's a cancer where, five years ago, we didn't know if it was one disease or many diseases lumped together," Simon adds. "We didn't know if it was inherited or if it was due to a sporadic mutation. And now we know exactly what the driver is and how it works, and we can start designing therapeutics."



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
Toothache
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
DNA Finger Printing Alcohol and Driving Liver Breast Cancer Women More Prone to Road Rage Weaver Syndrome Radiofrequency Ablation for Liver Cancer Tumors Hepatectomy Hepatomegaly 

Recommended Reading
Current Treatments for Liver Cancer
Current Treatments for Liver Cancer (also known as hepatoma or hepatocellular carcinoma) can result ...
Liver Cancer
Liver or hepatic cancer is an abnormal growth of cells in the liver. The leading cause of the ......
Radiofrequency Ablation for Liver Cancer Tumors
All you need to know on Radiofrequency Ablation (RFA) therapy for liver cancer including treatment, ...
Alcohol and Driving
Alcohol and driving do not mix. Drunken driving is the cause of many deaths in the world....
Breast Cancer
Breast cancer is a cancer that affects the breasts or mammary glands. Early detection and lifestyle ...
DNA Finger Printing
DNA fingerprinting is a technique which helps forensic scientists and legal experts solve crimes, id...
Hepatomegaly
Hepatomegaly or an enlarged liver can be a symptom or a complication of many different diseases whic...
Weaver Syndrome
Weaver syndrome is a genetic disorder in which children show accelerated bone growth, advanced bone ...
Women More Prone to Road Rage
If you find your self getting mad and cursing under your breath while driving, you are a victim of r...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use